TRIM21 and adenoviridae infectious disease: Consistent with complement and TRIM21 being antibody-dependent neutralization mechanisms, patients with agammaglobulinemia are more susceptible to adenovirus infections, which can be severe or even fatal (Schultz et al., 2008).